Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67.6M
-
Number of holders
-
238
-
Total 13F shares, excl. options
-
66M
-
Shares change
-
-1.38M
-
Total reported value, excl. options
-
$1.62B
-
Value change
-
-$79.8M
-
Put/Call ratio
-
1.48
-
Number of buys
-
120
-
Number of sells
-
-146
-
Price
-
$24.54
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q2 2023
314 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q2 2023.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 238 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66M shares
of 67.6M outstanding shares and own 97.58% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.97M shares), VANGUARD GROUP INC (7.01M shares), Capital World Investors (6.49M shares), FMR LLC (4.56M shares), EMINENCE CAPITAL, LP (3.12M shares), STATE STREET CORP (2.26M shares), Bellevue Group AG (2.09M shares), JANUS HENDERSON GROUP PLC (2.08M shares), Champlain Investment Partners, LLC (1.62M shares), and BROWN CAPITAL MANAGEMENT LLC (1.59M shares).
This table shows the top 238 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.